Login

President Satoshi Ogiso: Leading the Way Forward | Satoshi Ogiso - President & CEO of Hino Motors 00:10:00

Share On Facebook Share On Twitter

Satoshi Ogiso is President/CEO/Chro at Hino Motors Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Reid AI', deepfake concerns and state of AI arms race|Reid Hoffman,investor,Greylock
00:10:00
Nasdaq Interview Harness The Power of AI with Chad Steelberg | Chad Steelberg, CEO, Veritone IncVERI:NMQ
00:00:00
Sarah J. Chalmers, M.D. Critical Care Specialist, Mayo Clinic / Ask Mayo Clinic: Cystic Fibrosis
00:10:00
Osso CEO Eduardo Capelastegui highlights Neoenergia's key advancements in April, May, and June, focusing on...
00:10:00
Platinum Group Metals: Capitalizing on Palladium's Rise and Strategic Project Developments
00:10:00
Navigating Forward-Looking Statements and Risks in AIM ImmunoTech's Interview| Thomas Equels, CEO, AIM ImmunoTech Inc.
00:10:00
CEO Marita Zuraitis discusses leadership as Horace Mann announces the Principals of the Year award recipients.
00:10:00
Navigating Career Reentry: Sophie Yazdi and Mary-Helen Donovan on Empowering Working Mothers at T. Rowe Price
00:10:00
GHL Systems Berhad: CEO and IR Director Briefing | SEAN S. HESH - Group Chief Executive Officer of GHL Systems Berhad
00:10:00
public and private collaborations drive urban innovation|Julie Lein,Co-Founder and Managing Partner,Urban Innovation Fund
00:10:00
The video outlines Axiom's views, emphasizing their potential for change, the risks of investment, and that statements made are for informational purposes only and not guarantees of future performance.
00:10:00
Initialized GP Alda Leu Dennis on Negotiating Term Sheets|Alda Leu Dennis,General Partner,Initialized Capital

© 2017 - Neuhu+